Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HFA 24: MONITOR-HF Subgroup Analysis
Author(s): Jasper J Brugts Added: 1 year ago
HFA 24 - We are joined by Dr Jasper J Brugts (Erasmus University Medical Centre, NL) to discuss the findings of a predefined subgroup analysis of the MONITOR-HF study (NTR7672).MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation,… View more

Heart Failure
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 9 months ago

Heart Failure

Prevention & Chronic Conditions
Time in Target Ambulatory Blood Pressure Range Linked to Lower CV Risk
Added: 6 months ago Source:  Radcliffe Cardiology
A new meta-analysis suggests that the more time an individual's ambulatory blood pressure (ABP) is within the target range proposed by the 2024 European Society of Cardiology (ESC) guidelines, the lower their risk of mortality and cardiovascular events.¹ The findings also highlight that office blood pressure measurements frequently misclassify patients with regard to their actual blood pressure… View more

Demographic

Guidelines & Statements
HFA 24: The TELESAT Study
Author(s): Nicolas Girerd Added: 1 year ago
HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients… View more

Heart Failure

Digital Health
THT 2025 Conference Announces its Late-Breaking Scientific Sessions
Added: 1 year ago Source:  THT
THT conference has released its four late-breaking trial sessions for 2025.The fourth annual Technology and Heart Failure Therapeutics conference is set to take place from the 11th to 13th February at Omni Boston Hotel at the Seaport in Boston. Access the full programme here.Late Breaking Clinical Science Session ITuesday 11th February, 09:30 – 10:45am ESTRobotic Surgical Technique for Performing… View more

Heart Failure
HFA 24: Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF
Author(s): Michael Kiernan Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure… View more

Heart Failure

Digital Health
Luke Laffin
Job title: Preventive Cardiologist
Dr Luke Laffin is a physician in the Preventive Cardiology & Rehabilitation Section in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He sees patients at Cleveland Clinic main campus and is the medical director of cardiac rehabilitation. Specialty Interests: Cardiology, preventive cardiology, hypertension (high… View more
Research Area(s) / Expertise: Job title: Professor of Medicine and Director of Cardiomyopathy Program
DrLynne Stevenson is aProfessor of Medicine and Director of Cardiomyopathy Program atVanderbilt University Medical Center, Nashville, US. Herresearch experience includes acute and ambulatory hemodynamic monitoring, exercise physiology, heart failure hospitalisations and the interface of arrhythmias and sudden death risk with left ventricular dysfunction. View more
Kazuomi Kario
Job title: Professor and Chairman of Cardiovascular Medicine
Prof Kazuomi Kario is Professor and Chairman of Cardiovascular Medicine at Jichi Medical University School of Medicine in Shimotsuke, Japan. Prof Kario and his team were the first to demonstrate ’morning surge’ in blood pressure (BP) as an independent risk factor for cardiovascular disease (Kario et al. Circulation 2003) and first used ’morning hypertension’ with the definition of morning BP ≥135… View more
Rajiv Agarwal
Prof Rajiv Agarwal is an Emeritus Professor of Medicine at Indiana University School of Medicine in Indianapolis, US. He earned his medical degree from the All India Institute of Medical Sciences, New Delhi, India, and completed his nephrology fellowship at the University of Texas Southwestern in Dallas, US. He joined Indiana University in 1997, earning recognition such as the Trustee’s Teaching… View more